Financial Impact

For each migration the patient must undergo a new intervention for additional stent placement. With typical ERCP interventions costing $4,649, this can end up costing the hospital significantly.

  • BOSTON SCIENTIFIC WALLFLEX Biliary RX Fully Covered Stent has reported up to 13% migration rate (n = 156)1
  • GORE® VIABIL® Biliary Endoprosthesis reported migrations ranging from 0 to 1.4%1

Migration as well as lack of patency require additional intervention, resulting in additional hospital stays and increased hospital costs.

Total Patients
Estimated Savings
Reinterventions

Potential economic impact

If GORE® VIABIL® Biliary Endoprosthesis was used to treat 100 patients with unresectable malignant biliary strictures, your institution is estimated to annually:

Eliminate 16 reinterventions due to migrations and reduced patency, and save $116,716 versus using BOSTON SCIENTIFIC WALLFLEX Biliary RX Fully Covered Stent.

The average cost of a hospital inpatient ERCP with stent placement for patients without complications is approximately $4,649 (National healthcare payer database, 2015). Gore has used reasonable efforts to ensure the completeness and accuracy of the information contained herein as of the date this document was prepared. Gore is not liable for any claims or actions attributable to the use of this information, nor for any errors or omissions involved in the use of the information, or the results. Payment policies are variable depending on the payer, geographic location, and provider-specific contracts. The models provided here are for illustrative purposes only and are not intended to be indicative of payment from any payer.

    W. L. Gore & Associates, Inc.  Migration Summary for GORE® VIABIL® Biliary Endoprosthesis and BOSTON SCIENTIFIC WALLFLEX Biliary RX Fully Covered Stent. Flagstaff, AZ: W. L. Gore & Associates, Inc; 2017.  [Literature Summary].  AW0010-EN3. Krokidis M, Fanelli F, Orgera G, Bezzi M, Passariello R, Hatzidakis A.  Percutaneous treatment of malignant jaundice due to extrahepatic cholangiocarcinoma: covered Viabil stent versus uncovered Wallstents.  Cardiovascular & Interventional Radiology 2010;33(1):97-106. Kitano M, Yamashita Y, Tanaka K, et al.  Covered self-expandable metal stents with an anti-migration system improve patency duration without increased complications compared with uncovered stents for distal biliary obstruction caused by pancreatic carcinoma: a randomized multicenter trial.  Am J Gastroenterol.  2013 Nov;108(11):1713-22.

Residents of some states have the right to opt-out of the “sharing” or “selling” of their personal information. Gore does not "sell" the personal information of website users. Gore may "share" the personal information of website users, as standard advertising practice meant to offer you a more personalized service.

If you want to opt-out from Gore “sharing” your personal information, click on Opt-Out of Sharing to turn off the targeting cookies that we share with our advertising partners in order to provide you with personalized information. Disabling sharing will stop the use of cookies to targeted advertising but you may still see generic Gore ads.

Please note that your exercising of the rights outlined will have no adverse effect on the price and quality of our goods or services.

Opt-Out of Sharing

You Have Successfully Opted Out of the Sharing of Your Personal Information

Please note that if you clear your cookies and then use another device or browser, etc. your opt-out status is not transferred to the new device or browser.